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ABSTRACT  We  have  examined  acetylcholine  (ACh)-elicited  potentials  or  currents  in  current-  or 
voltage-clamped  cultured  myotubes  exposed  to  12-O-tetradecanoyl-phorbol-13-acetate  (TPA),  a 
potent tumor promoter that activates  protein kinase C. Although this agent had little action on either 
membrane  resting  potential  or  electrical  resistance,  a  reversible  decrease  in  ACh  sensitivity  was 
induced on 3-4-d-old chick myotubes. Depression of transmitter action by TPA was extended to 7- 
8-d mouse myotubes only when they were treated with phosphatidylserine.  Glyceryl dioleate  had 
effects  on  myotubes  similar  to  those  of TPA  but with  a reduced  efficacy.  We  conclude  that the 
activation  of protein  kinase  C might be involved  with the capacity of ACh receptors to respond to 
transmitter stimulation. 
Acetylcholine (ACh) ~ receptors located on specialized mem- 
brane regions of  innervated muscle fibers and on entire surface 
of denervated fibers or cultured myotubes become desensi- 
tized in the continued presence of the transmitter, owing to 
their inactivation (1).  However, the molecular mechanisms 
underlying this decrease in membrane chemosensitivity are 
still under question (2). Several recent findings indicate tight 
connections between the function of membrane ionic chan- 
nels and protein phosphorylation (3). In the present study we 
have examined the action of ACh on chick and mouse cul- 
tured  myotubes  in  the  presence  of the  tumor  promoting 
phorbol ester  12-O-tetradecanoyl-phorbol-13-acetate (TPA), 
a known activator of the calcium- and phospholipid-depend- 
ent protein kinase C (PrkC) (4-7). We show here a reversible 
decrease in the extent of ACh-induced depolarizations and an 
enhancement of  the rate of  AChR desensitization ofmyotubes 
exposed to TPA (10-6-10  -8 M). Thus, this study, in addition 
to its biological interest, might give some clues to the under- 
standing of the mechanism of receptor desensitization itself. 
MATERIALS  AND  METHODS 
We prepared  primary cultures of muscle cells from embryonic  chick muscle 
and from mouse (C57) adult muscle, as described earlier (8, 9). Electrophysio- 
logical recordings were made in cylindrical myotubes with a 20-50-urn  diam 
and an apparent  length of-200-300 #m, as described fully elsewhere (10-12). 
Iontophoretic  pulses of ACh were applied to a site ~20 #m from the recording 
pipette.  We applied  at  least three  different doses of ACh to each spot on a 
Abbreviations used in this paper. ACh, acetylcholine; Gl-dio, glyceryl 
dioleate;  MEM,  minimum essential medium; PrkC,  protein  kinase 
C; Ptd-Ser, phosphatidylserine; TPA, 12-O-tetradecanoyl-phorbol- 13- 
acetate. 
myotube surface to obtain  the  largest response  with  a  small  ACh  current. 
Chemosensitivity, conventionally  expressed as peak of depolarization  versus 
the charge passed through the ACh electrode (13), was calculated from data of 
the linear part of the dose-response  curve (10). Since depolarization  depends 
on  various  membrane parameters  (14), all  values of chemosensitivity  were 
corrected and referred to mean resting potential  and inversion potential  (15, 
16). Cultures  kept  at 37°C by irradiating  infrared  light were equilibrated  in 
standard  minimum essential medium (MEM) buffered with  10 mM HEPES/ 
NaOH (bath  volume,  1.5  ml). TPA, and in some cases ACh (as indicated  in 
the text), was applied by perfusion or added to the bathing fluid from a stock 
solution.  The  TPA  stock  solution  was  I  mM  in  1%  dimethyl  sulfoxide. 
Dimethyl  sulfoxide was ineffective in altering  ACh  sensitivity in the range 
0.01-4). 1%, the same used in the experiments. Phosphatidylserine (Ptd-Ser) and 
glyceryl dioleate (GI-dio) were applied in a bath after suspension in MEM by 
sonication for 2-3 rain at 4"C. All substances used were purchased from Sigma 
Chemical Co. (St. Louis, MO). 
RESULTS  AND  DISCUSSION 
Myotubes from 3-4-d primary cultures of chick embryo my- 
ogenic cells showed a  resting potential of-44.3  +  1.6  mV 
(mean _+ SEM; n  =  95) after a single electrode penetration. 
This value did not decrease significantly when a second elec- 
trode was inserted into the cell, and it remained stable for 2 
to 3 h. When cells were exposed to the potent tumor promoter 
TPA (10-6-10  -s M),  which  recognizes binding sites on the 
cell  membrane (for review see  references  17  and  18)  and 
induces dedifferentiative effects in chick myotubes (19),  the 
amplitude of their response to ionophoretic ACh exhibited a 
detectable decrease within 2-4 min. The decline of the ACh 
depolarization in the presence of TPA was maximal after 30- 
50  rain and concomitant with a decrease in absolute mem- 
brane potential. This decrease was too small to account for 
the decline in ACh response. The membrane input resistance 
(Rin) and equilibrium potential of ACh response (-4.8 _+ 0.6; 
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sensitivity determined  conventionally as  potential  change/ 
ACh charge (12)  was as low as 60%  of the resting value in 
some myotubes, 10% in others, after 30 min of TPA perfu- 
sion.  Membrane  potential  and  ACh  sensitivity  recovered 
promptly when the tumor promoter was removed from the 
bathing fluid. The recovery was complete when the myotube 
exposure did not exceed 60-80 min. TPA concentrations of 
<10  -8 M were ineffective in lowering ACh-induced depolari- 
zations. TPA concentrations of>10  -6 M were not tested. The 
membrane current induced by the action of ACh in voltage- 
clamped myotubes declined progressively by 50-70% during 
TPA application, with same time course as ACh-sensitivity. 
Fig.  1 and Table I give a summary of the results. 
As mentioned before, TPA is effective in inducing dediffer- 
entiative alterations in developing chick myotubes at a con- 
centration as low as 10  -7 M (19) but ineffective in promoting 
equivalent  morphological and  biochemical changes in  cul- 
tured mouse myotubes (20,  21).  Application of TPA (10  -6- 
10  -8  M)  on  mouse  myotubes  was  ineffective  in  lowering 
transmitter sensitivity and membrane potential,  in contrast 
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FIGURE  1  The effect of bath-applied TPA (10  -7 M)  on the ACh 
response  of three different 4-d-old  chick  myotubes.  (a-c)  ACh 
depolarization produced by iontophoresis to the surface of a cell 
before (a) and  after (b and  c) TPA exposure at indicated times. 
Values next to traces indicate membrane potential. (Top) Potential; 
(bottom) iontophoretic current.  (d) The time course of changes in 
membrane potential (triangles) and ACh sensitivity  (circles) mea- 
sured  at a myotube after TPA application. Arrows  indicate bath 
application of the drug and washing (W). (e and f) The membrane 
current activated by ACh before (e) and after (f) TPA exposure at 
indicated time. Holding potential, -50 mV. (Top) Membrane cur- 
rent; (bottom) iontophoretic current. 
to the effect seen in chick myotubes. 
Recent studies suggest that PrkC has a binding site for TPA 
(for review see reference 22), as the tumor promoter phorbol 
ester directly activates the enzyme both in vivo and in vitro. 
In in vitro PrkC activation both Ptd-Ser and calcium ions are 
indispensable  (23).  When  mouse  myotubes equlibrated  in 
MEM containing Ptd-Ser (100 #g/ml)were successively ex- 
posed to TPA (10-6-10  -8 M), their ACh sensitivity declined 
by 80-90% within 30 min, whereas their membrane potential, 
input resistance, and equilibrium potential for ACh response 
(-3.4 _+ 0.9  mV; n  =  7)  remained substantially stable (see 
Table I  and  Fig.  2).  TPA  was ineffective in  lowering ACh 
sensitivity when  myotubes were treated with  phosphatidyl- 
choline,  a  phospholipid  known  to  inhibit  PrkC  activation 
(23).  In contrast to chick myotube, which exhibited a  per- 
manent decrease  in  ACh  sensitivity during TPA exposure. 
ACh sensitivity of  the mouse myotube after a transient decline 
partially recovered within 20-60 min even in the presence of 
the agent (Fig.  2).  ACh  sensitivity was reduced  again  in  a 
subsequent exposure to TPA after a new treatment with Ptd- 
Ser and recovered completely after washing was done. 
During prolonged application of ACh, muscle cells become 
unresponsive (24). This is also true of  cultured chick myotubes 
but not of rat myotubes (25).  Bath application of ACh (10  -5 
M) depolarized the mouse myotubes to their reversal poten- 
tial, which was ~-5  mV in MEM as mentioned above. In 
contrast to rat myotubes, which do not exhibit desensitization 
(25), the ACh-induced depolarization in the mouse myotube 
could  be  sustained  for  periods  as  long  as  3-5  min,  and 
membrane potential reverted to original values within 5-10 
min after ACh bath application. For myotubes equilibrated 
in MEM containing Ptd-Ser (100 ug/ml) and TPA (10  -7 M) 
desensitization  was  more  pronounced,  and  the  membrane 
potential recovered to normal within  10-70 s after ACh bath 
application (10  -5 M). Repetitive iontophoretic ACh applica- 
tions (0.5-2 s,  10-50 hA, 0.1  Hz) could not desensitize ACh 
receptors in untreated myotubes. A degree of desensitization 
was induced by equivalent ACh applications in Ptd-Ser, TPA- 
treated myotubes (Fig. 2). 
When diacylglycerol, which is a physiological activator of 
PrkC (26),  was substituted for TPA in its unsaturated form 
(Gl-dio), it was less potent in reducing ACh sensitivity of the 
mouse Ptd-Ser-treated myotube with respect to TPA. In fact, 
Gl-dio  concentrations  of 3-7  x  10  -5  M  were  required  to 
reduce the myotube ACh sensitivity, and the effect was not 
as pronounced as with TPA added at  10  -7 M  (e.g.,  Fig.  3). 
For instance, in  12 cells examined ACh sensitivity was  16.5 
+ 4.8 vs 3.2 _+ 0.6 mV/nC determined after TPA application 
(Table I). The same result was obtained when chick myotubes 
not  treated  with  Ptd-Ser  were  equilibrated  in  MEM  and 
exposed to  Gl-dio  (7  x  10  -5  M).  Gl-dio  had  no  effect at 
concentrations <  2 x  10  -5 M. Since Gl-dio and Ptd-Ser are 
TABLE  I 
Effects of TPA (10  -7 M) on Electrical Parameters of Cultured Myotubes after 30 min of Drug Exposure 
4-d-old chick myotube 
7-d-old Ptd-Ser-treated 
mouse myotube 
Control  TPA 
RP  Ri,  •  RP  Rin  o" 
mV  m[~  mVlnC  mV  m~  mVInC 
--43.9 -  1.9 (57)  19 ± 3 (24)  49 ± 4.3 (54)  -31.1 ±  1.5 (27)  16 + 2 (21)  23.3 ± 4.1 (32) 
--39.6±1.7(31)  25+4(10)  27.8-+4.2(24)  -41.1 +1.1 (27)  23+3(10)  3.2±0.6(18) 
RP, membrane resting potential; Rjn, membrane input resistance; ~, Ach sensitivity. Number of observations is in brackets. 
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FIGURE 2  The effect Of bath-applied TPA (10  -7 M)  on the Ach 
response of five different mouse myotubes.  (a-c) ACh depolariza- 
tion produced by iontophoresis of ACh at a 7-d-old myotube: (a) 
control; (b)  10 min of TPA-exposure; (c)  10 min of TPA-exposure 
after treatment with Ptd-Ser (100 #g/ml). The top trace is membrane 
potential; iontophoretic current is on the bottom. Numbers next to 
traces  are  membrane resting  potentials.  (d)  The time course  of 
changes  in  ACh  sensitivity  induced  by  the  agent  at  a  8-d-old 
myotube. Notice a decreased ACh-sensitivity  only when cell was 
treated with Ptd-Ser (100 #g/ml) and its partial recovery during the 
exposure to TPA. Arrows as in Fig. I. Resting membrane potential, 
-41 mV; resting ACh sensitivity, 21 mV/nC. (e) ACh depolarization 
produced by bath-application of ACh (I0  -s M)in an untreated 8-d- 
old myotube. Membrane potential recovered within the next 7 rain. 
Number in near potential trace, membrane resting potential;  arrow, 
ACh application. (/) Fast desensitization  induced in a Ptd-Ser-, TPA- 
treated 8-d-old myotube (10 rain of treatment)  by bath application 
of ACh (I0  -s M). Number next to potential trace, membrane poten- 
tial. 
water insoluble,  in our system it is difficult to translate  the 
concentrations we used into physiological terms. It is known 
that diacylglycerol is transiently produced in membrane as a 
consequence  of extracellular  signals,  and  its  appearance  is 
always associated with activation of PrkC (22, 27). Thus, the 
apparent reduced efficacy of GI-dio as compared with that of 
TPA  might  be  related  to  its  rapid  degradation  in  the  cell 
membrane, as it occurs under physiological conditions, or to 
lack  of uptake  by the  myotubes  (due  for  instance  to  its 
inability to intercalate into the membrane [28]). 
In some experiments chick myotubes from 3-4-d primary 
cultures or mouse 7-8-d myotubes treated with Ptd-Ser (100 
~m/ml) were exposed to 4-alpha-phorbol- 12,13-didecanoate, 
an analogue of TPA inactive in promoting tumors and unable 
to activate the  enzyme (4,  29).  The application  of 4-alpha- 
phorbol- 12,13-didecanoate at a concentration as low as 10  -6- 
10  -7 M under the same experimental conditions as described 
before could not induce any electrical change on myotubes. 
Concentrations of > 10  -6 M  were not tested. 
The results  reported  here  show that  the tumor promoter 
TPA (10 -6-10  -8 M) induced in the chick myotube a reversible 
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FIGURE 3  The time course of changes in ACh-sensitivity  induced 
by Gl-dio (3  x  10  -5 M)  and TPA (I0  -z M)  at an 8-d-old  mouse 
myotube. Notice the decline of ACh sensitivity only when the cell 
was treated with Ptd-Ser (I 00/~m/ml), and its recovery after washing 
(W), Arrows as  in  Fig. 1.  Resting membrane potential, -50  mY; 
resting ACh sensitivity, 49 mV/nC. 
decrease in its receptor-mediated chemosensitivity. This effect 
is extended to the mouse myotube in the stringent presence 
of Ptd-Ser, but it fails to occur when TPA is substituted with 
4-alpha-phorbol- 12,13-didecanoate, or Ptd-Ser with phospha- 
tidylcholine. Unsaturated diacylglycerol acts on myotubes in 
a way similar to TPA but with a markedly reduced potency. 
Since in other in vivo and in vitro systems PrkC is activated 
under the same experimental  conditions that we have used 
(22,  26),  the  main  conclusion of the  present  report  is that 
PrkC activation  is involved in some way, either directly or 
indirectly, with either the production in the number of func- 
tional  ACh  receptors or their  capacity to  respond  to ACh 
stimulation. It is known that muscarinic-cholinergic agonists 
induce  a  rapid  hydrolysis  of polyphosphoinositides  in  the 
plasma membrane of their target cells to yield diacylglycerol, 
a potent activator of PrkC (22, 26, 27). It remains to be seen 
whether analogous biochemical processes underlying protein 
phosphorylation, which may be involved in transmitter-sen- 
sitivity decline, are induced by ACh at the nicotinic-cholin- 
ergic receptors. 
As mentioned before, mouse myotubes are unresponsive to 
tumor promoters,  and  we  have  shown  here  that  TPA  was 
ineffective on mouse myotubes unless in the presence of Ptd- 
Ser.  Since an approximate correlation  is described between 
the ability of TPA to promote tumors and to activate PrkC 
(4),  tumor promotion  might be  somehow regulated  by the 
composition and the organization of membrane lipids indis- 
pensable in PrkC activation. 
The  suggestion  from the  present  data that  a  decrease  in 
transmitter  sensitivity of some muscle diseases  (10,  30,  31) 
might be mediated by an increased phosphoinositide turnover 
is intriguing idea worthy of further study. 
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